Review of the pharmacodynamics of antibiotic use in animal food productionFLOREA, Naomi F; NIGHTINGALE, Charles H.Diagnostic microbiology and infectious disease. 2004, Vol 49, Num 2, pp 105-108, issn 0732-8893, 4 p.Article

Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosingDAWEI XUAN; NICOLAU, David P; NIGHTINGALE, Charles H et al.International journal of antimicrobial agents. 2004, Vol 23, Num 3, pp 291-295, issn 0924-8579, 5 p.Article

Production and resolution of cantharidin-induced inflammatory blistersMAGLIO, Dana; NIGHTINGALE, Charles H; NICOLAU, David P et al.International journal of antimicrobial agents. 2003, Vol 22, Num 1, pp 77-80, issn 0924-8579, 4 p.Article

Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hostsBABALOLA, Chinedum P; NIGHTINGALE, Charles H; NICOLAU, David P et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 6, pp 1098-1100, issn 0305-7453, 3 p.Article

Circulating tumor necrosis factor-alpha production during the progression of rat endotoxic sepsisDAWEI XUAN; NICOLAU, David P; NIGHTINGALE, Charles H et al.Chemotherapy (Basel). 2001, Vol 47, Num 3, pp 194-202, issn 0009-3157Article

Effect of adjunctive treatment with gamma interferon against Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hostsBABALOLA, Chinedum P; NIGHTINGALE, Charles H; NICOLAU, David P et al.International journal of antimicrobial agents. 2004, Vol 24, Num 3, pp 219-225, issn 0924-8579, 7 p.Article

Optimizing pharmacodynamic target attainment using the MYSTIC antibiogram: Data collected in North America in 2002KUTI, Joseph L; NIGHTINGALE, Charles H; NICOLAU, David P et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 7, pp 2464-2470, issn 0066-4804, 7 p.Article

Simultaneous determination of ticarcillin and clavulanate in rabbit serum and tissue cage fluid by liquid chromatographyCHONGHUA LI; QIUMING GENG; NICOLAU, David P et al.Journal of chromatography. B. 2003, Vol 794, Num 2, pp 227-236, issn 1570-0232, 10 p.Article

Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeineKIM, Myo-Kyoung; NIGHTINGALE, Charles H; NICOLAU, David P et al.Clinical pharmacokinetics. 2003, Vol 42, Num 11, pp 985-996, issn 0312-5963, 12 p.Article

Comparison of the bactericidal activity of trovafloxacin and ciprofloxacin, alone and in combination with cefepime, against Pseudomonas aeruginosaMCNABB, Jocarol; QUINTILIANI, Richard; NIGHTINGALE, Charles H et al.Chemotherapy (Basel). 2000, Vol 46, Num 6, pp 383-389, issn 0009-3157Article

Determination of BMS-284756, a new quinolone, in mouse serum by high-performance liquid chromatography with fluorescence detectionDAWEI XUAN; TURLEY, Christina; NIGHTINGALE, Charles H et al.Journal of chromatography. B, Biomedical sciences and applications. 2001, Vol 765, Num 1, pp 37-43, issn 1387-2273Article

Determination of the in vivo pharmacodynamic profile of cefepime against extended-spectrum-beta-lactamase-producing Escherichia coli at various inoculaMAGLIO, Dana; ONG, Christine; BANEVICIUS, Mary Anne et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 6, pp 1941-1947, issn 0066-4804, 7 p.Article

Efficacy of clarithromycin against Streptococcus pneumoniae expressing mef(A)-mediated resistanceMAGLIO, Dana; CAPITANO, Blair; BANEVICIUS, Mary Anne et al.International journal of antimicrobial agents. 2004, Vol 23, Num 5, pp 498-501, issn 0924-8579, 4 p.Article

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumoniaTESSIER, Pamela R; KIM, Myo-Kyoung; WEN ZHOU et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 5, pp 1425-1434, issn 0066-4804Article

Extended interval aminoglycoside dosing: from concept to clinicMAGLIO, Dana; NIGHTINGALE, Charles H; NICOLAU, David P et al.International journal of antimicrobial agents. 2002, Vol 19, Num 4, pp 341-348, issn 0924-8579Conference Paper

Quantitation of tigecycline, a novel glycyclcycline, by liquid chromatographyCHONGHUA LI; SUTHERLAND, Christina A; NIGHTINGALE, Charles H et al.Journal of chromatography. B. 2004, Vol 811, Num 2, pp 225-229, issn 1570-0232, 5 p.Article

Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilitiesBABALOLA, Chinedum P; PATEL, Kalpana B; NIGHTINGALE, Charles H et al.International journal of antimicrobial agents. 2004, Vol 23, Num 4, pp 343-348, issn 0924-8579, 6 p.Article

Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenemKUTI, Joseph L; DANDEKAR, Prachi K; NIGHTINGALE, Charles H et al.Journal of clinical pharmacology. 2003, Vol 43, Num 10, pp 1116-1123, issn 0091-2700, 8 p.Article

Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumpsONG, Christine T; TESSIER, Pamela R; CHONGHUA LI et al.Diagnostic microbiology and infectious disease. 2007, Vol 57, Num 2, pp 153-161, issn 0732-8893, 9 p.Article

Impact of extended-spectrum β -lactamase -producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs : A matched cohort studySU YOUNG LEE; KOTAPATI, Srividya; KUTI, Joseph L et al.Infection control and hospital epidemiology. 2006, Vol 27, Num 11, pp 1226-1232, issn 0899-823X, 7 p.Article

Pharmacodynamics of moxifloxacin and levofloxacin at simulated epithelial lining fluid drug concentrations against Streptococcus pneumoniaeFLOREA, Naomi R; TESSIER, Pamela R; CUILIAN ZHANG et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 4, pp 1215-1221, issn 0066-4804, 7 p.Article

Pharmacokinetic profile of meropenem, administered at 500 milligrams every 8 hours, in plasma and cantharidin-induced skin blister fluidMAGLIO, Dana; RENLI TENG; THYRUM, Per T et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1771-1773, issn 0066-4804, 3 p.Article

Pharmacodynamic study of β-lactams alone and in combination with β-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible β-lactamaseCHONGHUA LI; NICOLAU, David P; LISTER, Philip D et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 2, pp 297-304, issn 0305-7453, 8 p.Article

Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oralKUTI, Joseph L; LE, Thuy N; NIGHTINGALE, Charles H et al.American journal of health-system pharmacy. 2002, Vol 59, Num 22, pp 2209-2215, issn 1079-2082, 7 p.Conference Paper

Pharmacokinetic and pharmacodynamic profile of high dose extended interval piperacillin-tazobactamKIM, Myo-Kyoung; XUAN, Dawei; QUINTILIANI, Richard et al.Journal of antimicrobial chemotherapy (Print). 2001, Vol 48, Num 2, pp 259-267, issn 0305-7453Article